Rifaximin
- Level
- Commodity
- Parent
- 51283600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51283604This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L36O5T016N. European Medicines Agency schedules Rifaximin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10312MIG. Rifaximin generally arises in the molecular formula C43H51N3O11. The term RIFAXIMIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) RIFAXIMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rifaximin under HS 29419000 and SITC 54139. As of Q4 2014, RIFAXIMIN remains the US FDA Preferred Term for this commodity. Rifaximin bears US NLM identifiers UMLS ID C0073374 and NCI Concept Code C61926. SMILES: O(C1C(C(O)C(C(O)C(C)C=CC=C(C(=O)NC2C3N4C(NC3C3C5C(OC(OC=CC(OC)C1C)(C5=O)C)C(C(O)C3C2O)C)CC(CC4)C)C)C)C)C(=O)C.
Same parent
Under 51283600 · 12Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.